proteomics
-
Scripps Spinout Belharra Unveils $130M to Catch Next Big Wave of Drug Discovery
Versant Ventures-backed Belharra Therapeutics has launched with $130 million in funding and a partnership with Roche subsidiary Genentech. The startup’s technology analyzes proteins in the context of the entire cell, enabling it to discover molecules that bind to targets previously deemed undruggable.
-
Artificial Intelligence, BioPharma, Diagnostics, Pharma, SYN
Nautilus Bio lines up SPAC merger and $350M in funding for proteomics R&D
Nautilus, among the biotechs developing protein analysis tools for drug discovery and diagnostics, already has a partnership with Genentech. As it prepares to go public, Nautilus aims to do for proteomics what Illumina did for genomics.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Proteomics shows promise for assessing risk of heart attacks and strokes
In a study published in JAMA, researchers at UCSF used an innovative protein measurement assay developed by healthcare technology company SomaLogic to detect 1,130 different proteins in the plasma of nearly 2,000 individuals already diagnosed with coronary heart disease.
-
Proteomics assay startup gets funding from UM’s student-run fund
Ann Arbor proteomics startup Phasiq got a small cash infusion from the University of Michigan’s student-run commercialization fund. It’ll use that funding to scale its multiplex assays.
-
Right after Novartis takes stake in proteomics company, it raises $16.5M
Just a few weeks after Novartis announced it’s taken an ownership stake in Colorado’s SomaLogic, the […]